Béla Kocsis (Bela Kocsis)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 13

Top Venues

Life (Basel, Switzerland)

Antibiotics (Basel, Switzerland)

Microorganisms

Acta microbiologica et immunologica Hungarica

Semmelweis Egyetem

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Semmelweis Egyetem Jan 01 2014

Hungary

assistant professor :: Institute of Medical Microbiology

Semmelweis University Jan 01 2012 - Dec 31 2013

Hungary

medical doctor :: Institute of Medical Microbiology

University of Verona Jan 01 2009 - Dec 31 2011

Italy

PhD student :: Institute of Pathology and Diagnostics

Semmelweis University Oct 01 2006 - Dec 31 2008

Hungary

medical doctor :: Institute of Medical Microbiology

Publications

Balazs Stercz, Judit Domokos, Zsuzsanna A Dunai, Nora Makra, Janos Juhasz, Eszter Ostorházi, Béla Kocsis, Dora Szabo
The Roles of a Multidrug-Resistant Klebsiella pneumoniae High-Risk Clone and Its Resistance Plasmids on the Gastrointestinal Colonization and Host-Defense Effectors in the Gut. Antibiotics (Basel, Switzerland) 13 (8) (2024)
Balazs Stercz, Judit Domokos, Zsuzsanna A Dunai, Nora Makra, Janos Juhasz, Eszter Ostorházi, Béla Kocsis, Dora Szabo
The Roles of a Multidrug-Resistant Klebsiella pneumoniae High-Risk Clone and Its Resistance Plasmids on the Gastrointestinal Colonization and Host-Defense Effectors in the Gut. Antibiotics (Basel, Switzerland) 13 (8) (2024)
Dániel Gulyás, Katalin Kamotsay, Dóra Szabó, Béla Kocsis
Investigation of Delafloxacin Resistance in Multidrug-Resistant Escherichia coli Strains and the Detection of E. coli ST43 International High-Risk Clone. Microorganisms 11 (6) (2023)
Béla Kocsis
Hypervirulent Klebsiella pneumoniae: An update on epidemiology, detection and antibiotic resistance. Acta microbiologica et immunologica Hungarica (2023)
Dániel Gulyás, Katalin Kamotsay, Dóra Szabó, Béla Kocsis
Investigation of Delafloxacin Resistance in Multidrug-Resistant Escherichia coli Strains and the Detection of E. coli ST43 International High-Risk Clone. Microorganisms 11 (6) (2023)
Béla Kocsis, Dániel Gulyás, Dóra Szabó
Emergence and Dissemination of Extraintestinal Pathogenic High-Risk International Clones of Escherichia coli . Life (Basel, Switzerland) 12 (12) (2022)
Béla Kocsis, Dániel Gulyás, Dóra Szabó
Emergence and Dissemination of Extraintestinal Pathogenic High-Risk International Clones of Escherichia coli . Life (Basel, Switzerland) 12 (12) (2022)
Béla Kocsis, Dániel Gulyás, Dóra Szabó
Emergence and Dissemination of Extraintestinal Pathogenic High-Risk International Clones of Escherichia coli . Life (Basel, Switzerland) 12 (12) (2022)
Béla Kocsis, Dániel Gulyás, Dóra Szabó
Emergence and Dissemination of Extraintestinal Pathogenic High-Risk International Clones of Escherichia coli . Life (Basel, Switzerland) 12 (12) (2022)
Béla Kocsis, Dániel Gulyás, Dóra Szabó
Delafloxacin, Finafloxacin, and Zabofloxacin: Novel Fluoroquinolones in the Antibiotic Pipeline. Antibiotics (Basel, Switzerland) 10 (12) (2021)
Béla Kocsis, Dániel Gulyás, Dóra Szabó
Diversity and Distribution of Resistance Markers in Pseudomonas aeruginosa International High-Risk Clones. Microorganisms 9 (2) (2021)
Orsolya Szabo, Béla Kocsis, Nikolett Szabo, Katalin Kristof, Dora Szabo
Contribution of OqxAB Efflux Pump in Selection of Fluoroquinolone-Resistant Klebsiella pneumoniae. The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale 2018 (2018)
Béla Kocsis, Zoltán Tiszlavicz, Gabriella Jakab, Réka Brassay, Márton Orbán, Ágnes Sárkány, Dóra Szabó
Case report of Actinomyces turicensis meningitis as a complication of purulent mastoiditis. BMC infectious diseases 18 (1) (2018)

Béla Kocsis.css-eqlu8i{font-size:small;padding-left:4px;} (Bela Kocsis)

Publication Activity (10 Years)

Top Topics

Top Venues

Béla Kocsis (Bela Kocsis)